These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
973 related items for PubMed ID: 10565771
1. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, Shyr Y, Leach SD. J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771 [Abstract] [Full Text] [Related]
2. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD. Ann Surg; 1999 May; 229(5):729-37; discussion 737-8. PubMed ID: 10235532 [Abstract] [Full Text] [Related]
6. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, Nagai A, Ohnuki T, Nishikawa T, Kusakabe K. J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611 [Abstract] [Full Text] [Related]
8. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT. Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [Abstract] [Full Text] [Related]
9. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. Asagi A, Ohta K, Nasu J, Tanada M, Nadano S, Nishimura R, Teramoto N, Yamamoto K, Inoue T, Iguchi H. Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206 [Abstract] [Full Text] [Related]
10. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. Yun M, Choi HS, Yoo E, Bong JK, Ryu YH, Lee JD. J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305 [Abstract] [Full Text] [Related]
12. Detection of liver metastases from pancreatic cancer using FDG PET. Fröhlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN. J Nucl Med; 1999 Feb; 40(2):250-5. PubMed ID: 10025831 [Abstract] [Full Text] [Related]
13. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics. Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R. J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193 [Abstract] [Full Text] [Related]
19. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases]. Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X. Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458 [Abstract] [Full Text] [Related]